JP2023522030A5 - - Google Patents

Info

Publication number
JP2023522030A5
JP2023522030A5 JP2022562646A JP2022562646A JP2023522030A5 JP 2023522030 A5 JP2023522030 A5 JP 2023522030A5 JP 2022562646 A JP2022562646 A JP 2022562646A JP 2022562646 A JP2022562646 A JP 2022562646A JP 2023522030 A5 JP2023522030 A5 JP 2023522030A5
Authority
JP
Japan
Prior art keywords
igg
modified
constant domain
feline
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022562646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522030A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/027839 external-priority patent/WO2021212084A1/en
Publication of JP2023522030A publication Critical patent/JP2023522030A/ja
Publication of JP2023522030A5 publication Critical patent/JP2023522030A5/ja
Pending legal-status Critical Current

Links

JP2022562646A 2020-04-17 2021-04-16 ネコ科動物抗体バリアント Pending JP2023522030A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063011491P 2020-04-17 2020-04-17
US63/011,491 2020-04-17
PCT/US2021/027839 WO2021212084A1 (en) 2020-04-17 2021-04-16 Feline antibody variants

Publications (2)

Publication Number Publication Date
JP2023522030A JP2023522030A (ja) 2023-05-26
JP2023522030A5 true JP2023522030A5 (https=) 2024-04-22

Family

ID=75870744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022562646A Pending JP2023522030A (ja) 2020-04-17 2021-04-16 ネコ科動物抗体バリアント

Country Status (17)

Country Link
US (2) US20240067730A1 (https=)
EP (1) EP4136109A1 (https=)
JP (1) JP2023522030A (https=)
KR (1) KR20230005158A (https=)
CN (1) CN115667300A (https=)
AU (1) AU2021257355A1 (https=)
BR (1) BR112022020631A2 (https=)
CA (1) CA3176434A1 (https=)
CL (2) CL2022002856A1 (https=)
CO (1) CO2022014684A2 (https=)
EC (1) ECSP22080858A (https=)
IL (1) IL297290A (https=)
MX (1) MX2022012793A (https=)
PE (1) PE20230348A1 (https=)
PH (1) PH12022552743A1 (https=)
TW (1) TW202204404A (https=)
WO (1) WO2021212084A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12297272B2 (en) 2017-08-15 2025-05-13 Eianco US inc. IgG Fc variants for veterinary use
CN113544153B (zh) 2019-01-03 2024-12-10 因外泰克斯公司 用于增加治疗剂在犬中的半衰期的组合物及使用方法
CN120590527A (zh) 2020-05-11 2025-09-05 因外泰克斯公司 用于增加治疗剂在犬中的半衰期的组合物和使用方法
JP7796415B2 (ja) * 2020-06-10 2026-01-09 株式会社バイカ・セラピュティクス エリスロポエチンポリペプチドを含む融合タンパク質
KR20230038522A (ko) 2020-07-10 2023-03-20 인베티엑스 인코포레이티드 고양이에서 치료제의 반감기를 증가시키기 위한 조성물 및 사용 방법
WO2022072446A1 (en) 2020-09-29 2022-04-07 Zoetis Services Llc Feline antibody variants
WO2025166165A1 (en) * 2024-02-01 2025-08-07 Zoetis Services, Llc Compositions and methods for modifying antibody effector functions

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6284471B1 (en) 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US5698762A (en) 1994-12-09 1997-12-16 Dauerman; Leonard Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons
US20030031671A1 (en) 2001-08-01 2003-02-13 Sydney Welt Methods of treating colon cancer utilizing tumor-specific antibodies
AU2005285347A1 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US8546543B2 (en) 2004-11-12 2013-10-01 Xencor, Inc. Fc variants that extend antibody half-life
AU2005304624B2 (en) 2004-11-12 2010-10-07 Xencor, Inc. Fc variants with altered binding to FcRn
HRP20150279T1 (hr) * 2007-12-26 2015-05-08 Xencor, Inc. Fc inaäśice s promijenjenim vezanjem na fcrn
WO2012024650A2 (en) 2010-08-19 2012-02-23 Abbott Laboratories Anti-ngf antibodies and their use
US8790651B2 (en) 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
CA2875783C (en) 2012-06-06 2018-12-11 Zoetis Llc Caninized anti-ngf antibodies and methods thereof
US10093731B2 (en) * 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use
US20210388053A1 (en) * 2018-10-18 2021-12-16 Kindred Biosciences, Inc. Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use
JP7536294B2 (ja) * 2018-12-05 2024-08-20 株式会社バイカ・セラピュティクス 抗体のFc領域改変体

Similar Documents

Publication Publication Date Title
JP2023522030A5 (https=)
JP2023522029A5 (https=)
JP7181612B2 (ja) アルカリ安定性免疫グロブリン結合タンパク質
JP2024026255A5 (https=)
CN110382529B (zh) 工程化的异源二聚体蛋白质
JP5812303B2 (ja) 酸性域での親和性が低下したプロテインa変異型タンパク質及び抗体捕捉剤
JP2020506898A5 (https=)
CN110520445B (zh) 抗pd-l1/抗pd-1天然抗体结构样异源二聚体形式双特异抗体及其制备
KR102247704B1 (ko) 항 pd-1/항 her2 천연항체 구조 형태의 헤테로다이머 계의 이중특이성 항체 및 그 제조방법
IL276286B1 (en) FC variants with improved binding to FCRN and extended half-life
US20100168395A1 (en) Novel polypeptide, an affinity chromatography material, and a method for separating and/or purifying immunoglobulin
JP2023543262A5 (https=)
WO2021120095A1 (zh) 抗聚合酶的单克隆抗体及其应用
CN102892885A (zh) IgA结合性肽以及利用其的IgA的纯化
CA2645675C (en) Adsorbents for protein purification
JPH10257893A5 (https=)
EP3054009A1 (en) PROTEIN COMPRISED BY LINKING BY LINKER MULTIPLE DOMAINS HAVING AFFINITY FOR PROTEINS HAVING Fc PART OF IMMUNOGLOBULIN G (IgG)
JP2023542737A5 (https=)
AU2024230594A1 (en) Photoswitchable compounds and affinity ligands, and their use for the optical control of affinity matrices
RU2023105687A (ru) Варианты кошачьих антител
JP2015019615A (ja) プロテインgの細胞膜外ドメイン変異体の新規な改変型タンパク質
CN117700501A (zh) 免疫球蛋白结合蛋白及其应用
JP2024522092A5 (https=)
RU2024136642A (ru) Мутанты собачьих антител
JP2015003872A (ja) マウスIgGの精製方法